Ave Maria Biotechnology's Unattributed - III Round

Ave Maria Biotechnology raised a round of funding on April 22, 2014.

Ave Maria Biotechnology (AVB) is dedicated to the discovery, development and commercialization of safe, effective and ethical stem cell technologies for regenerative medicine, oncology and fully human…

Articles about Ave Maria Biotechnology's Unattributed - III Round: